Again! The AHZ OF 2013 WOW.
20M traded in a day, massive upbeat anns yet arvo sell off, 8.7c to 9.7c looks real cheap for $5B of income potential. It was 16.0c SP not that long ago. Brokers keep calling 22c to 28c except motley fool who are against it now.
When those CC results come in from 150 operations a month in april n centres are 85, and HSV2 ph2 come in good, what will sp be then? More than 9.3c I think. Whipsaw move, management pulling fingers out on tanked sp going to the hidden draws must have known of all this in advance.
well done to pattersons they called weaker 4c CC sales initially but then massive move up H2. Looks correct now. Japan approval next through Pr Ozaki from eacts conference. Hope sp stays this low so we can make more buys neven bigger profits of 3 to 4 bagger this year by august.
Now thats the AHZ of 2013..im lovin it. Volatility is back, while we were talkin science pitt st kids were pulling our pants down. But what a great volatility.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus expands CardioCel market
Ann: Admedus expands CardioCel market, page-112
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online